ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 271 filers reported holding ALKERMES PLC in Q3 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,012 | -10.1% | 143,223 | +0.4% | 0.01% | 0.0% |
| Q2 2023 | $4,464 | -1.2% | 142,618 | -11.0% | 0.01% | 0.0% |
| Q1 2023 | $4,519 | -11.2% | 160,307 | -17.7% | 0.01% | -14.3% |
| Q4 2022 | $5,090 | -99.9% | 194,806 | +1.0% | 0.01% | +16.7% |
| Q3 2022 | $4,306,000 | -22.8% | 192,821 | +3.0% | 0.01% | -14.3% |
| Q2 2022 | $5,575,000 | +81.7% | 187,138 | +60.4% | 0.01% | +133.3% |
| Q1 2022 | $3,069,000 | +17.5% | 116,662 | +3.9% | 0.00% | 0.0% |
| Q4 2021 | $2,612,000 | -24.8% | 112,276 | -0.3% | 0.00% | -25.0% |
| Q3 2021 | $3,474,000 | -13.8% | 112,641 | -31.5% | 0.00% | 0.0% |
| Q2 2021 | $4,031,000 | +21.5% | 164,400 | -7.4% | 0.00% | 0.0% |
| Q1 2021 | $3,318,000 | -15.8% | 177,600 | -10.1% | 0.00% | 0.0% |
| Q4 2020 | $3,942,000 | +3.2% | 197,600 | -14.2% | 0.00% | -20.0% |
| Q3 2020 | $3,818,000 | -21.5% | 230,400 | -8.0% | 0.01% | -16.7% |
| Q2 2020 | $4,861,000 | +23.4% | 250,500 | -8.3% | 0.01% | 0.0% |
| Q1 2020 | $3,940,000 | -29.3% | 273,200 | 0.0% | 0.01% | -14.3% |
| Q4 2019 | $5,573,000 | +0.7% | 273,200 | -3.7% | 0.01% | 0.0% |
| Q3 2019 | $5,535,000 | -16.1% | 283,700 | -3.0% | 0.01% | -12.5% |
| Q2 2019 | $6,595,000 | -37.6% | 292,600 | +1.1% | 0.01% | -42.9% |
| Q1 2019 | $10,564,000 | +22.6% | 289,500 | -0.8% | 0.01% | +16.7% |
| Q4 2018 | $8,614,000 | -32.2% | 291,900 | -2.5% | 0.01% | -20.0% |
| Q3 2018 | $12,707,000 | +3.1% | 299,400 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $12,323,000 | -50.8% | 299,400 | -30.7% | 0.02% | -51.6% |
| Q1 2018 | $25,038,000 | +3.7% | 431,994 | -2.0% | 0.03% | +6.9% |
| Q4 2017 | $24,136,000 | +5.7% | 440,994 | -1.8% | 0.03% | 0.0% |
| Q3 2017 | $22,833,000 | -9.7% | 449,120 | +3.0% | 0.03% | -12.1% |
| Q2 2017 | $25,275,000 | +31.0% | 435,994 | +32.2% | 0.03% | +26.9% |
| Q1 2017 | $19,287,000 | +1.8% | 329,701 | -3.3% | 0.03% | -3.7% |
| Q4 2016 | $18,945,000 | +23.7% | 340,865 | +4.7% | 0.03% | +22.7% |
| Q3 2016 | $15,318,000 | +0.1% | 325,700 | -8.0% | 0.02% | 0.0% |
| Q2 2016 | $15,300,000 | +32.9% | 354,000 | +5.1% | 0.02% | +22.2% |
| Q1 2016 | $11,512,000 | -59.1% | 336,700 | -5.1% | 0.02% | -58.1% |
| Q4 2015 | $28,173,000 | +37.3% | 354,910 | +1.4% | 0.04% | +30.3% |
| Q3 2015 | $20,525,000 | +523.7% | 349,845 | +583.9% | 0.03% | +560.0% |
| Q2 2015 | $3,291,000 | +378.3% | 51,154 | +353.1% | 0.01% | +400.0% |
| Q1 2015 | $688,000 | -39.0% | 11,290 | -41.4% | 0.00% | -50.0% |
| Q4 2014 | $1,128,000 | +33.8% | 19,260 | -2.0% | 0.00% | +100.0% |
| Q3 2014 | $843,000 | +69.6% | 19,655 | +98.9% | 0.00% | 0.0% |
| Q2 2014 | $497,000 | -84.5% | 9,880 | -87.5% | 0.00% | -80.0% |
| Q4 2013 | $3,208,000 | +20.9% | 78,900 | 0.0% | 0.01% | +25.0% |
| Q3 2013 | $2,653,000 | +13.8% | 78,900 | -3.0% | 0.00% | 0.0% |
| Q2 2013 | $2,332,000 | – | 81,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |